Cristers, a France-based pharmaceutical company that markets generic and OTC products, has chosen Adents Prodigi cloud serialisation solution to ensure compliance with the EU Falsified Medicines Directive and offer beyond-compliance ROI, it was reported yesterday.

Adents Prodigi is jointly developed with Microsoft and powered by Azure and is claimed to enable secure data exchange and help leverage the power of serialisation data to improve business practices. Adents serialisation solutions are designed to help companies to receive simplified speed to compliance with regulatory requirements.

The Adents Prodigi cloud-based Level 4 traceability solution met all of Cristers' requirements. The company says that the solution mainly manages regulatory requirements, offers an easy on-boarding process to connect multiple trading partners, and facilitates significant business improvements by allowing companies to use the massive amounts of data generated during the serialisation and track & trace process.